health care

California Gov. Jerry Brown has on his desk a bill that aims to protect patients' pocketbooks when they're billed for treatment by an out-of-network provider at an in-network facility.

Researchers analyzing recent drug spending in the U.S. say that high-priced drugs for rare diseases aren't having a widespread or significant effect on overall health care spending.

The company's lobbying of state legislatures is just one factor in EpiPen's dominance of the market. Manufacturers of competing devices have struggled to gain a foothold.

The American Academy of Pediatrics doesn't recommend using the nasal spray flu vaccine. In late August, the federal Centers for Disease Control and Prevention concluded it wasn't up to snuff.

Finding a provider of health care in your network is often a challenge because the insurer's directory isn't up to date. A California law aims to improve directory accuracy.

The nurses oppose the company's demand to end health care plans sponsored by the nurse's union and replace them with corporate-sponsored plans which have higher deductibles and out-of-pocket costs.

Four years after user fees were imposed to speed up the review of generic drug applications by the Food and Drug Administration, more than 4,000 generics remain in limbo.

That's what 76 percent said in a recent Kaiser Family Foundation survey. Half the respondents also said they'd be uncomfortable traveling to places in Florida where mosquitoes are spreading Zika.